Analysis of 604 ER-negative and 1,463 ER-positive breast cancer patients revealed that survivin segregated with ER-negative tumors (two-tailed P < 0.05) in 12 out of 16 cohorts (Table 2). This evidence concerns the gene ESR1 and breast carcinoma.